GNE-0877

N/A

Report date: 2024/12/06 20:00:46
NME

Base Information

Drug NameGNE-0877
Drug Alias NameGNE-0877DNL-201DNL201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeucine-rich repeat serine/threonine-protein kinase 2 inhibitors
TargetsLeucine-rich repeat serine/threonine-protein kinase 2
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenentech IncF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenentech Inc
Inactive CompaniesDenali Therapeutics Inc
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A